PDCD1LG2 and cancer: In addition, as observed in univariate analyses, high PD-L2 levels in both cancer and stromal cells were associated with elevated risk of progression compared with patients with low cancer cell and/or low stroma cell PD-L2 (HR, 1.9; 95% CI, 1.3 to 2.7; P = .003; Data Supplement).